Mara A. Cafferata

580 total citations
23 papers, 399 citations indexed

About

Mara A. Cafferata is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Mara A. Cafferata has authored 23 papers receiving a total of 399 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Mara A. Cafferata's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (8 papers) and Pleural and Pulmonary Diseases (4 papers). Mara A. Cafferata is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (8 papers) and Pleural and Pulmonary Diseases (4 papers). Mara A. Cafferata collaborates with scholars based in Italy, United Kingdom and United States. Mara A. Cafferata's co-authors include Andrea Ardizzoni, Francesco Grossi, M. Paganuzzi, Rosangela Filiberti, Paola Marroni, Marcello Tiseo, Lucia Tixi, M Chiaramondia, Alessandra Bearz and Riccardo Puntoni and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

Mara A. Cafferata

23 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mara A. Cafferata Italy	10	243	195	68	68	51	23	399
Lucia Tixi Italy	12	202 0.8×	276 1.4×	46 0.7×	54 0.8×	68 1.3×	26	398
L. Sengeløv Denmark	9	130 0.5×	139 0.7×	240 3.5×	76 1.1×	31 0.6×	23	379
Julien Volet France	10	119 0.5×	262 1.3×	109 1.6×	51 0.8×	60 1.2×	23	361
Romano Scalerta Italy	9	72 0.3×	176 0.9×	86 1.3×	92 1.4×	37 0.7×	16	372
Till Plönes Germany	12	224 0.9×	180 0.9×	39 0.6×	85 1.3×	44 0.9×	53	406
Philip Philip United States	9	173 0.7×	361 1.9×	143 2.1×	61 0.9×	86 1.7×	23	480
Bertrand Filleul Belgium	8	84 0.3×	69 0.4×	33 0.5×	59 0.9×	15 0.3×	14	265
G. Rangoni Italy	10	68 0.3×	111 0.6×	69 1.0×	45 0.7×	19 0.4×	26	362
Avgust M. Garin Russia	4	177 0.7×	276 1.4×	77 1.1×	101 1.5×	39 0.8×	7	408
Jess Frank United States	10	183 0.8×	153 0.8×	51 0.8×	38 0.6×	51 1.0×	13	323

Countries citing papers authored by Mara A. Cafferata

Since Specialization

Citations

This map shows the geographic impact of Mara A. Cafferata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mara A. Cafferata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mara A. Cafferata more than expected).

Fields of papers citing papers by Mara A. Cafferata

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mara A. Cafferata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mara A. Cafferata. The network helps show where Mara A. Cafferata may publish in the future.

Co-authorship network of co-authors of Mara A. Cafferata

This figure shows the co-authorship network connecting the top 25 collaborators of Mara A. Cafferata. A scholar is included among the top collaborators of Mara A. Cafferata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mara A. Cafferata. Mara A. Cafferata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Boni, C., Marcello Tiseo, Luca Boni, et al.. (2012). Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST). British Journal of Cancer. 106(4). 658–665. 19 indexed citations

Manzini, Vincenzo de Pangher, Mara A. Cafferata, Camillo Porta, et al.. (2009). Malignant peritoneal mesothelioma: a multicenter study on 81 cases. Annals of Oncology. 21(2). 348–353. 73 indexed citations

Tiseo, Marcello, Andrea Ardizzoni, Mara A. Cafferata, et al.. (2008). Predictive and prognostic significance of neuron-specific enolase (NSE) in non-small cell lung cancer.. PubMed. 28(1B). 507–13. 23 indexed citations

Ardizzoni, Andrea, Mara A. Cafferata, Marcello Tiseo, et al.. (2006). Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer. Cancer. 107(12). 2842–2849. 91 indexed citations

Ardizzoni, Andrea, Mara A. Cafferata, Lucia Tixi, et al.. (2005). Induction Chemotherapy With Carboplatin–Paclitaxel Followed by Standard Radiotherapy With Concurrent Daily Low-Dose Cisplatin Plus Weekly Paclitaxel for Inoperable Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 28(1). 58–64. 1 indexed citations

Filiberti, Rosangela, Paola Marroni, Monica Neri, et al.. (2005). Serum PDGF-AB in Pleural Mesothelioma. Tumor Biology. 26(5). 221–226. 37 indexed citations

Cafferata, Mara A., M Chiaramondia, Francesco Monetti, & Andrea Ardizzoni. (2004). Complete spontaneous remission of non-small-cell lung cancer: a case report. Lung Cancer. 45(2). 263–266. 23 indexed citations

Zaniboni, Alberto, Andrea Ardizzoni, Filippo de Marinis, et al.. (2003). Phase II Study of Taxol Combined With Ifosfamide and Carboplatin in the Treatment of Stage IIIb–IV Non-Small-Cell Lung Cancer. American Journal of Clinical Oncology. 26(1). 84–88. 6 indexed citations

Filiberti, Rosangela, Paola Marroni, M. Paganuzzi, et al.. (2002). c-erbB-2 protein in serum of primary lung cancer patients. Cancer Detection and Prevention. 26(1). 64–68. 7 indexed citations

10.

Baldini, Editta, Andrea Ardizzoni, Tiziana Prochilo, et al.. (2001). Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC). British Journal of Cancer. 85(10). 1452–1455. 8 indexed citations

11.

Ardizzoni, Andrea, Mara A. Cafferata, M. Paganuzzi, et al.. (2001). Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma. Cancer. 92(7). 1896–1904. 29 indexed citations

12.

Ardizzoni, Andrea, Mara A. Cafferata, M. Paganuzzi, et al.. (2001). Study of pretreatment serum levels of HER‐2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma. Cancer. 92(7). 1896–1904. 2 indexed citations

13.

Ratto, Giovanni Battista, Mara A. Cafferata, Paolo Bruzzi, et al.. (2000). Phase II Study of Combined Immunotherapy, Chemotherapy, and Radiotherapy in the Postoperative Treatment of Advanced Non–Small–Cell Lung Cancer. Journal of Immunotherapy. 23(1). 161–167. 16 indexed citations

14.

Neri, Monica, Elio Geido, Rosangela Filiberti, et al.. (2000). Analysis of Erythrocyte Glycophorin‐A Variants by Flow Cytometry in Lung Disease Patients Detects the Effect of Tobacco Smoke. Analytical Cellular Pathology. 21(1). 35–40. 4 indexed citations

15.

Ardizzoni, Andrea, Giovanna Antonelli, Francesco Grossi, et al.. (1999). The combination of etoposide and cisplatin in non-small-cell lung cancer (NSCLC). Annals of Oncology. 10. S13–S17. 19 indexed citations

16.

Baldini, Editta, Andrea Ardizzoni, Mara A. Cafferata, et al.. (1999). Combined gemcitabine, ifosfamide and vinorelbine (GIN): activity and safety of a non-platinum-based regimen in advanced non-small-cell lung cancer (NSCLC). European Journal of Cancer. 35. S264–S264. 1 indexed citations

17.

Grossi, Francesco, M.C. Pennucci, Lucia Tixi, Mara A. Cafferata, & Andrea Ardizzoni. (1998). Management of Malignant Pleural Effusions. Drugs. 55(1). 47–58. 25 indexed citations

18.

Ardizzoni, Andrea, Mara A. Cafferata, & Riccardo Rosso. (1998). EPOETINA ALFA NEI TUMORI DEL POLMONE. Tumori Journal. 84(6_suppl1). S20–S26. 2 indexed citations

19.

Boni, Luca, M.C. Pennucci, Andrea Ardizzoni, et al.. (1997). 9 Factors affecting response rate (RR) and survival (OS) in advanced non-small-cell lung cancer (NSCLC): Retrospective analysis on 1128 patients (pts). Lung Cancer. 18. 5–5. 1 indexed citations

20.

Baldini, Editta, Andrea Ardizzoni, M.C. Pennucci, et al.. (1995). 1059 Cisplatin, Vindesine, Mitomycin (MVP) vs Cisplatin, Ifosfamide, Navelbine (PIN) vs Carboplatin, Navelbine (CAN) in advanced non-small cell lung cancer (NSCLC). European Journal of Cancer. 31. S221–S222. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact